|

Liver Cancer Clinical Trials in Alabama

12 recruiting studies across 3 cities

All Trials in Alabama

Phase
Trial Phase Location
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsPhase 1/2Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsPhase 1Birmingham
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2Birmingham
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCCPhase 1/2Birmingham
DESTINY-PANTUMOUR04—Birmingham
Observational Study Protocol: LIVER-R—Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/ABirmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Birmingham
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCCPhase 1/2Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2Birmingham
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3Birmingham
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerPhase 1Dothan

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.